| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5549 | Xantholipin B | Novel antibiotic, showing 3- to 10-fold greater cytotoxicity than Xantholipin against a select panel of human cancer cell lines, demonstrating powerful antimicrobial activity against both Gram-positive bacteria and fungi |
|
| DCC5550 | XAX-162 | Quantity (mg or Unit) Unit Price ($/mg or $/Unit) Final Price 100 $26.55 Total: $2,655.00 50 $30.68 Total: $1,534.00 25 $35.99 Total: $899.75 10 $42.48 Total: $424.80 5 $50.15 Total: $250.75 |
|
| DCC5551 | xc-409 | Novel PKM2 activator |
|
| DCC5552 | Xen103 | Potent and Selective Stearoyl-CoA Desaturase-1 Inhibitor |
|
| DCC5553 | Xie18-6 | Novel INK4C inhibitor, specifically blocking the bioactivity of p18 protein and promoting human and murine hematopoietic stem cell ex vivo expansion |
|
| DCC5554 | Xist Ligand X1 | Novel non-coding RNA prototype Xist ligand, specifically binding the RepA motif of Xist, reducing the conformational space of RepA, displacing cognate interacting protein factors (PRC2 and SPEN), suppressing histone H3K27 trimethylation, and blocking init |
|
| DCC5555 | Xl-13n | Novel dual inhibitor of AF9 and ENL YEATS domains |
|
| DCC5556 | Xl-147 | Novel Potent Pan-Filovirus Inhibitor, showing potent inhibition against infectious EBOV Zaire (0.09 μM) and MARV (0.64 μM) |
|
| DCC5557 | Xl-418 | Novel Akt1/2 inhibitor |
|
| DCC5558 | Xr9051 Hydrochloride | Potent modulator of P-glycoprotein-mediated multidrug resistance (MDR), inhibiting the binding of cytotoxics to P-glycoprotein |
|
| DCC5559 | Xstax-vhll | Novel selective β-catenin degrader |
|
| DCC5560 | Xylariamide A | Carbonic anhydrase inhibitor; Fungal metabolite |
|
| DCC5561 | Xylarianaphthol-1 | Novel activator of p21 promoter in a p53-independent manner |
|
| DCC5562 | Y08624 | Novel TRIM24/BRPF1 dual inhibitor with IC 50 values of 0.98 and 1.16 μM, respectively |
|
| DCC5563 | Y2 Antagonist 36 | Novel non-peptidic highly potent, soluble and selective NPY Y2 antagonist |
|
| DCC5564 | Y2-antagonist-2 | Novel, selective, soluble non-peptidic NPY Y2 receptor antagonist with enhanced CNS exposure |
|
| DCC5565 | Y-39983 Dihydrochloride | Selective Rho-associated kinase (ROCK) inhibitor |
|
| DCC5566 | Yak037 | Tamoxifen-analog that Suppresses Glial L-Glutamate Transport Activity without Interaction with Estrogen_receptor>Estrogen Receptors |
|
| DCC5567 | Ycw-e11 | Novel Inhibitor of Antiapoptotic Bcl-2 Family Proteins |
|
| DCC5568 | Yh18968 | Novel GPR119 Agonist, improving glucose tolerance and augmenting the glucose lowering effect as well as the plasma level of active GLP-1 in normal mice in combination treatment with a dipeptidyl peptidase 4 (DPP-4) inhibitor |
|
| DCC5569 | Yh-gka | Novel glucokinase activator, significantlt decreasing in blood glucose levels with no adverse effects on serum lipids or body weight |
|
| DCC5570 | Yk-5-252 | Novel dual action combretastatin A-4 (CA-4) prodrug, releasing CA-4 through a disulfide bond cleavage mechanism and containing a near-infrared (NIR) fluorophore |
|
| DCC5571 | Ykl-05-093 | Novel salt inducible kinase (SIK) inhibitor, increasing bone formation and bone mass |
|
| DCC5572 | Ylt192 | Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy |
|
| DCC5573 | Ylt205 | Novel Inducer of Apoptosis in Human Colorectal Cells via Mitochondrial Apoptosis Pathway, Inhibiting Tumor Growth |
|
| DCC5574 | Ym-17690 | Novel non-analogous leukotriene agonist |
|
| DCC5575 | ym-201627 | Selective growth inhibitor of endothelial cells |
|
| DCC5576 | Ym-244769 Featured | YM-244769 is a potent, selective and orally active Na+/Ca2+ exchanger (NCX) inhibitor. YM-244769 preferentially inhibits NCX3 and suppresses the unidirectional outward NCX current (Ca2+ entry mode), with IC50s of 18 nM and 50 nM, respectively. YM-244769 efficiently protects against hypoxia/reoxygenation-induced SH-SY5Y neuronal cell damage. YM-244769 can also increase urine volume and urinary excretion of electrolytes in mice. |
|
| DCC5577 | ym-298198 Dihydrochloride | Potent and selective mGLu1 antagonist |
|
| DCC5578 | Ym-90k | Novel AMPA receptor antagonist |
|
